Incidence, risk factors and clinical features of venous thromboembolism in newly diagnosed lymphoma patients: Results from a prospective cohort study with Asian population

Thrombosis Research

Volumn 130, Issue 3, 2012, Pages e6-

  Park, Lee Chun ^a,b   Woo, Sook Young ^c   Kim, Seonwoo ^c   Jeon, Hyejin ^c   Ko, Young Hyeh ^a   Kim, Seok Jin ^a   Kim, Won Seog ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Kosin University   (South Korea)

^c Samsung Medical Center   (South Korea)

Author keywords

Lymphoma; Risk factor; Venous thromboembolism

Indexed keywords

ENOXAPARIN; METHOTREXATE; RITUXIMAB; WARFARIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ASIAN; CANCER CHEMOTHERAPY; CLINICAL FEATURE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GROUPS BY AGE; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; INCIDENCE; LARGE CELL LYMPHOMA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; RISK FACTOR; VENOUS THROMBOEMBOLISM;

EID: 84865252869     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.03.019     Document Type: Article

References (32)

1. D. Bergqvist Venous thromboembolism and cancer: prevention of VTE Thromb Res 102 2001 V209 V213
2. A.Y. Lee, and M.N. Levine Venous thromboembolism and cancer: risks and outcomes Circulation 107 2003 I17 I21
3. A.K. Kakkar, M. Levine, H.M. Pinedo, R. Wolff, and J. Wong Venous thrombosis in cancer patients: insights from the FRONTLINE survey Oncologist 8 2003 381 388
4. P. Prandoni, A. Falanga, and A. Piccioli Cancer and venous thromboembolism Lancet Oncol 6 2005 401 410
5. J.W. Blom, C.J. Doggen, S. Osanto, and F.R. Rosendaal Malignancies, prothrombotic mutations, and the risk of venous thrombosis JAMA 293 2005 715 722
6. P.D. Stein, A. Beemath, F.A. Meyers, E. Skaf, J. Sanchez, and R.E. Olson Incidence of venous thromboembolism in patients hospitalized with cancer Am J Med 119 2006 60 68
7. H.K. Chew, T. Wun, D. Harvey, H. Zhou, and R.H. White Incidence of venous thromboembolism and its effect on survival among patients with common cancers Arch Intern Med 166 2006 458 464
8. A.A. Khorana, C.W. Francis, E. Culakova, N.M. Kuderer, and G.H. Lyman Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy J Thromb Haemost 5 2007 632 634
9. V. Caruso, A. Di Castelnuovo, S. Meschengieser, M.A. Lazzari, G. de Gaetano, and S. Storti Thrombotic complications in adult patients with lymphoma: a meta-analysis of 29 independent cohorts including 18 018 patients and 1149 events Blood 115 2010 5322 5328
10. M. Mohren, I. Markmann, K. Jentsch-Ullrich, M. Koenigsmann, G. Lutze, and A. Franke Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis Br J Cancer 92 2005 1349 1351
11. R.S. Komrokji, N.P. Uppal, A.A. Khorana, G.H. Lyman, K.L. Kaplan, and R.I. Fisher Venous thromboembolism in patients with diffuse large B-cell lymphoma Leuk Lymphoma 47 2006 1029 1033
12. A.A. Khorana, C.W. Francis, E. Culakova, N.M. Kuderer, and G.H. Lyman Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients Cancer 110 2007 2339 2346
13. X. Zhou, S. Teegala, A. Huen, Y. Ji, L. Fayad, and F.B. Hagemeister Incidence and risk factors of venous thromboembolic events in lymphoma Am J Med 123 2010 935 941
14. A.A. Khorana, C.W. Francis, E. Culakova, and G.H. Lyman Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study Cancer 104 2005 2822 2829
15. M.J. Jang, S.M. Bang, and D. Oh Incidence of venous thromboembolism in Korea: from the Health Insurance Review and Assessment Service database J Thromb Haemost 9 2011 85 91
16. N.A. Zakai, and L.A. McClure Racial Differences in Venous Thromboembolism J Thromb Haemost 2011
17. K. Yokoyama, M. Murata, Y. Ikeda, and S. Okamoto Incidence and risk factors for developing venous thromboembolism in Japanese with diffuse large b-cell lymphoma Thromb Res 2011 [Electronic publication ahead of print]
18. G.H. Lyman Venous thromboembolism in the patient with cancer: focus on burden of disease and benefits of thromboprophylaxis Cancer 117 2011 1334 1349
19. W. Ageno Recent advances in the management of venous thromboembolism Korean J Hematol 45 2010 8 13
20. A. Falanga, M. Marchetti, A. Vignoli, and D. Balducci Clotting mechanisms and cancer: implications in thrombus formation and tumor progression Clin Adv Hematol Oncol 1 2003 673 678
21. M.B. Donati, and A. Falanga Pathogenetic mechanisms of thrombosis in malignancy Acta Haematol 106 2001 18 24
22. S.M. Bang, M.J. Jang, D. Oh, Y.K. Kim, I.H. Kim, and S.S. Yoon Korean guidelines for the prevention of venous thromboembolism J Korean Med Sci 25 2011 1553 1559
23. G.L. Nicolson, and S.E. Custead Effects of chemotherapeutic drugs on platelet and metastatic tumor cell-endothelial cell interactions as a model for assessing vascular endothelial integrity Cancer Res 45 1985 331 336
24. A.A. Shlebak, and D.B. Smith Incidence of objectively diagnosed thromboembolic disease in cancer patients undergoing cytotoxic chemotherapy and/or hormonal therapy Cancer Chemother Pharmacol 39 1997 462 466
25. A. Falanga, and M. Marchetti Venous thromboembolism in the hematologic malignancies J Clin Oncol 27 2009 4848 4857
26. T. Wun, and R.H. White Venous thromboembolism in patients with acute leukemia, lymphoma, and multiple myeloma Thromb Res 125 Suppl. 2 2010 S96 S102
27. D. Lekovic, P. Miljic, and B. Mihaljevic Increased risk of venous thromboembolism in patients with primary mediastinal large B-cell lymphoma Thromb Res 126 2011 477 480
28. N. Goldschmidt, E. Linetsky, E. Shalom, D. Varon, and T. Siegal High incidence of thromboembolism in patients with central nervous system lymphoma Cancer 98 2003 1239 1242
29. H. Ottinger, C. Belka, G. Kozole, M. Engelhard, P. Meusers, and D. Paar Deep venous thrombosis and pulmonary artery embolism in high-grade non Hodgkin's lymphoma: incidence, causes and prognostic relevance Eur J Haematol 54 1995 186 194
30. N. Levitan, A. Dowlati, S.C. Remick, H.I. Tahsildar, L.D. Sivinski, and R. Beyth Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data Medicine (Baltimore) 78 1999 285 291
31. S. Vescia, A.K. Baumgartner, V.R. Jacobs, M. Kiechle-Bahat, A. Rody, and S. Loibl Management of venous port systems in oncology: a review of current evidence Ann Oncol 19 2008 9 15
32. B. Yildizeli, T. Lacin, H.F. Batirel, and M. Yuksel Complications and management of long-term central venous access catheters and ports J Vasc Access 5 2004 174 178